C07K 14/4753
Hepatocyte growth factor
Official title: {Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II}
C07K14/4753 (Hepatocyte growth factor) appears on 146 US grants and 200 published applications in this corpus.
Search patents in C07K- Granted patents
- 146
- Published applications
- 200
- Assignees
- 125
- Inventors
- 423
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 6 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 9 | 0 |
| 1998 | 5 | 0 |
| 1999 | 6 | 0 |
| 2000 | 2 | 0 |
| 2001 | 6 | 1 |
| 2002 | 1 | 4 |
| 2003 | 3 | 11 |
| 2004 | 6 | 10 |
| 2005 | 1 | 6 |
| 2006 | 4 | 8 |
| 2007 | 3 | 10 |
| 2008 | 4 | 7 |
| 2009 | 3 | 10 |
| 2010 | 13 | 14 |
| 2011 | 4 | 11 |
| 2012 | 6 | 3 |
| 2013 | 6 | 6 |
| 2014 | 3 | 7 |
| 2015 | 6 | 7 |
| 2016 | 2 | 5 |
| 2017 | 4 | 7 |
| 2018 | 4 | 5 |
| 2019 | 5 | 10 |
| 2020 | 5 | 8 |
| 2021 | 6 | 8 |
| 2022 | 4 | 13 |
| 2023 | 4 | 7 |
| 2024 | 2 | 14 |
| 2025 | 4 | 4 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Self-assembling peptide5 May 2026US 12,617,827 B2Kanagawa Institute of Industrial Science and Technology
- Recombinant proteins and their therapeutic uses10 Mar 2026US 12,570,708 B2
- Method for producing an active hepatocyte growth factor (HGF)12 Aug 2025US 12,384,824 B2Eisai R&D Management Co., Ltd.
- Nucleoside modified mRNA and uses thereof29 Jul 2025US 12,371,666 B2Boston Medical Center Corporation
- Composition for increasing the expression of a growth factor gene, comprising coreshell structured microparticles as active ingredient22 Apr 2025US 12,280,155 B2G&P Bioscience Co., Ltd.
- Compositions and methods for prevention and treatment of corneal haze and scarring18 Jun 2026US 2026/0166123 A1Massachusetts Eye and Ear Infirmary
- Nucleic acid construct comprising utr and use thereof7 May 2026US 2026/0125672 A1Shanghai Regenelead Therapies Co., Ltd.
- Treatment of mst1 related diseases and disorders26 Feb 2026US 2026/0055410 A1Empirico Inc.
- Aav vector optimized for intrathecal administration into which hepatocyte growth factor gene is introduced15 Jan 2026US 2026/0015628 A1Helixmith Co., Ltd
- Spinal cord injury therapeutic targeting from acute phase to subacute phase18 Dec 2025US 2025/0381247 A1Keio University
Most cited
By later US patents
- Hepatocyte growth factor receptor agonists and uses thereof54US 6,099,841 AGenentech, Inc. · 2000
- Single-chain hepatocyte growth factor variants45US 5,316,921 AGenentech, Inc. · 1994
- Hepatocyte growth factor44US 5,004,805 AMitsubishi Kasei Corporation · 1991
- Nucleic acids encoding hepatocyte growth factor receptor antagonist antibodies32US 5,646,036 AGenentech, Inc. · 1997
- Hepatocyte growth factor variants30US 5,547,856 AGenentech, Inc. · 1996